Computational methods for fragment-based ligand design: growing and linking.

Fragment-based drug design has proved itself as a powerful technique for increasing the sampling and diversity of chemical space and enabling the design of novel leads and compounds. Computational techniques for identifying fragments, binding sites and particularly for linking, growing, and evolving fragments play a significant role in the process. Information from ADME studies and clustering property information in the form of toxicophores and chemotypes can play a significant role in aiding the design of novel, selective fragments with good activity profiles.

[1]  Roderick E Hubbard,et al.  How well can fragments explore accessed chemical space? A case study from heat shock protein 90. , 2011, Journal of medicinal chemistry.

[2]  Alexander D. MacKerell,et al.  Reproducing Crystal Binding Modes of Ligand Functional Groups Using Site-Identification by Ligand Competitive Saturation (SILCS) Simulations , 2011, J. Chem. Inf. Model..

[3]  P. Hirth,et al.  Vemurafenib: the first drug approved for BRAF-mutant cancer , 2012, Nature Reviews Drug Discovery.

[4]  Glenn J. Myatt,et al.  LeadScope: Software for Exploring Large Sets of Screening Data , 2000, J. Chem. Inf. Comput. Sci..

[5]  M. Congreve,et al.  Recent developments in fragment-based drug discovery. , 2008, Journal of medicinal chemistry.

[6]  J. Kazius,et al.  Derivation and validation of toxicophores for mutagenicity prediction. , 2005, Journal of medicinal chemistry.

[7]  J Andrew McCammon,et al.  LigMerge: A Fast Algorithm to Generate Models of Novel Potential Ligands from Sets of Known Binders , 2012, Chemical biology & drug design.

[8]  Tao Lu,et al.  Fragment-based strategy for structural optimization in combination with 3D-QSAR , 2013, Journal of Computer-Aided Molecular Design.

[9]  Matthias Rarey,et al.  Recore: A Fast and Versatile Method for Scaffold Hopping Based on Small Molecule Crystal Structure Conformations , 2007, J. Chem. Inf. Model..

[10]  Jürgen Bajorath,et al.  Assessment of Molecular Similarity from the Analysis of Randomly Generated Structural Fragment Populations. , 2006 .

[11]  Saskia Nijmeijer,et al.  Virtual Fragment Screening: Discovery of Histamine H3 Receptor Ligands Using Ligand-Based and Protein-Based Molecular Fingerprints , 2012, J. Chem. Inf. Model..

[12]  Daniel A Erlanson,et al.  Learning from our mistakes: the 'unknown knowns' in fragment screening. , 2013, Bioorganic & medicinal chemistry letters.

[13]  Michael M. Hann,et al.  RECAP — Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry. , 1998 .

[14]  P. Hajduk,et al.  Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.

[15]  Thierry Kogej,et al.  Scaffold Hopping by Fragment Replacement , 2013, J. Chem. Inf. Model..

[16]  G. Bemis,et al.  BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease. , 2004, Journal of medicinal chemistry.

[17]  Jean-Louis Reymond,et al.  Visualisation of the chemical space of fragments, lead-like and drug-like molecules in PubChem , 2011, J. Comput. Aided Mol. Des..

[18]  Alexandre Varnek,et al.  Estimation of the size of drug-like chemical space based on GDB-17 data , 2013, Journal of Computer-Aided Molecular Design.

[19]  Ulrike Schmidt,et al.  SuperToxic: a comprehensive database of toxic compounds , 2008, Nucleic Acids Res..

[20]  Corinna Blasse,et al.  FragmentStore—a comprehensive database of fragments linking metabolites, toxic molecules and drugs , 2010, Nucleic Acids Res..

[21]  Irene Nobeli,et al.  SERAPhiC: A Benchmark for in Silico Fragment-Based Drug Design , 2011, J. Chem. Inf. Model..

[22]  Dima Kozakov,et al.  FTMAP: extended protein mapping with user-selected probe molecules , 2012, Nucleic Acids Res..

[23]  Christopher W Murray,et al.  Experiences in fragment-based drug discovery. , 2012, Trends in pharmacological sciences.

[24]  Eugen Lounkine,et al.  Formal concept analysis for the identification of molecular fragment combinations specific for active and highly potent compounds. , 2008, Journal of medicinal chemistry.

[25]  Jacob D. Durrant,et al.  AutoClickChem: Click Chemistry in Silico , 2012, PLoS Comput. Biol..

[26]  Raed Khashan,et al.  FragVLib a free database mining software for generating "Fragment-based Virtual Library" using pocket similarity search of ligand-receptor complexes , 2012, Journal of Cheminformatics.

[27]  Michael P. Mazanetz,et al.  Hit and Lead Identification from Fragments , 2013 .

[28]  L. Mario Amzel,et al.  Impact of linker strain and flexibility in the design of a fragment-based inhibitor , 2009, Nature chemical biology.

[29]  J Andrew McCammon,et al.  AutoGrow 3.0: an improved algorithm for chemically tractable, semi-automated protein inhibitor design. , 2013, Journal of molecular graphics & modelling.

[30]  Robert J. Jilek,et al.  AllChem: generating and searching 1020 synthetically accessible structures , 2007, J. Comput. Aided Mol. Des..

[31]  Saskia Nijmeijer,et al.  Small and colorful stones make beautiful mosaics: fragment-based chemogenomics. , 2013, Drug Discovery Today.

[32]  Jean-Louis Reymond,et al.  Visualisation and subsets of the chemical universe database GDB-13 for virtual screening , 2011, J. Comput. Aided Mol. Des..

[33]  Designed chemical libraries for hit / lead optimisation The integration of high-throughput synthetic chemistry with sophisticated library design technology offers advantages in terms of speed and generality , .

[34]  Mike Cherry,et al.  Introduction to Fragment‐Based Drug Discovery , 2008 .

[35]  G. Petsko,et al.  Multiple solvent crystal structures: probing binding sites, plasticity and hydration. , 2006, Journal of molecular biology.

[36]  Qiang Wang,et al.  A fragment-based approach to the SAMPL3 Challenge , 2012, Journal of Computer-Aided Molecular Design.

[37]  Woody Sherman,et al.  Hole filling and library optimization: application to commercially available fragment libraries. , 2012, Bioorganic & medicinal chemistry.

[38]  Hans-Joachim Böhm,et al.  LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads , 1992, J. Comput. Aided Mol. Des..

[39]  Ramaswamy Nilakantan,et al.  CONFIRM: connecting fragments found in receptor molecules , 2008, J. Comput. Aided Mol. Des..

[40]  Amedeo Caflisch,et al.  Fragment-Based de Novo Ligand Design by Multiobjective Evolutionary Optimization. , 2008 .

[41]  Dragos Horvath,et al.  In Silico Fragment-Based Drug Discovery: Setup and Validation of a Fragment-to-Lead Computational Protocol Using S4MPLE , 2013, J. Chem. Inf. Model..

[42]  William J. Welsh,et al.  Fragment-based Shape Signatures: a new tool for virtual screening and drug discovery , 2013, Journal of Computer-Aided Molecular Design.

[43]  Valerie J. Gillet,et al.  SPROUT: A program for structure generation , 1993, J. Comput. Aided Mol. Des..

[44]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[45]  Matthias Rarey,et al.  Feature trees: A new molecular similarity measure based on tree matching , 1998, J. Comput. Aided Mol. Des..

[46]  Minoru Kanehisa,et al.  The KEGG database. , 2002, Novartis Foundation symposium.

[47]  Thomas Sander,et al.  Toxicity-Indicating Structural Patterns , 2006, J. Chem. Inf. Model..